Physician profile
Anna M Bui
NPI 1720209471
$1,085.25
in general payments reported to CMS, 2019-2025
23 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $256 · 2022: $172 · 2023: $244 · 2024: $235 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.12 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $139.84 | 2021-2024 | Orthovisc, Monovisc |
| Ferring Pharmaceuticals INC. | $132.27 | 2021-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $93.96 | 2021 | |
| Astellas Pharma US INC | $74.99 | 2025 | |
| Smith+Nephew, INC. | $60.12 | 2022-2024 | Collagenase Santyl |
| Si-Bone, INC. | $60.06 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $56.16 | 2021-2023 | |
| Janssen Biotech, INC. | $55.14 | 2021-2025 | Carvykti |
| Avanos Medical | $47.55 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $47.35 | 2025 | Libtayo |
| Sobi, INC | $43.57 | 2024 | |
| Bioventus LLC | $40.02 | 2022 | |
| Apellis Pharmaceuticals, INC. | $30.88 | 2025 | |
| Radius Health, INC. | $30.71 | 2023 | Tymlos |
| Kyowa Kirin, INC. | $28.26 | 2023 | Crysvita |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $28.23 | 2023 | Seglentis |
| Ibsa Pharma INC. | $24.59 | 2022 | |
| Heron Therapeutics, INC. | $17.27 | 2022 | |
| Electronic Waveform Lab, INC. | $17.23 | 2021 | |
| Abbvie INC. | $17.02 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $15.26 | 2024 | |
| Djo, LLC | $12.76 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.